Applicant, as named in the Orange Book

Bausch And Lomb Inc

Next listed expiry: Lumify on 14 Jul 2030. 6 products with live protection, 6 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Lumify brimonidine tartrate	brimonidine tartrate	208144	14 Jul 2030	patent, carve-out possible
Lumify Preservative Free brimonidine tartrate	brimonidine tartrate	218424	14 Jul 2030	patent, carve-out possible
Xiidra lifitegrast	lifitegrast	208073	18 Dec 2033	patent
Lotemax Sm loteprednol etabonate	loteprednol etabonate	208219	23 Dec 2036	patent
Miebo perfluorohexyloctane	perfluorohexyloctane	216675	21 Jun 2037	patent, carve-out possible
Xipere triamcinolone acetonide	triamcinolone acetonide	211950	16 Apr 2040	patent

Recent events

25 Oct 2026Atropine Sulfate · Generic approved 15 Apr 2026
25 Oct 2026Atropine Sulfate · Generic approved 31 Jul 2026
25 Oct 2026Atropine Sulfate · Generic approved 16 Oct 2026

Products without listed protection (6)

Drug	Ingredient	NDA	Earliest generic entry	Basis
Atropine Sulfate atropine sulfate	atropine sulfate	213581	open now	no listed protection
Bepreve bepotastine besilate	bepotastine besilate	022288	open now	no listed protection
Lotemax loteprednol etabonate	loteprednol etabonate	202872	open now	no listed protection
Timoptic · 2 strengths timolol maleate	timolol maleate	018086	open now	no listed protection
Timoptic In Ocudose · 2 strengths timolol maleate	timolol maleate	019463	open now	no listed protection
Timoptic-Xe · 2 strengths timolol maleate	timolol maleate	020330	open now	no listed protection